Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Comment by MBAon May 09, 2019 9:00am
186 Views
Post# 29728047

RE:Beacon Securities forecast

RE:Beacon Securities forecastI noticed that as well. Seems like a glaring error on Doug's part. Q1 is done and guidance is good for Q2, with VMD very likely to continue its revenue growth at 10%, so I have 2019 revenues at $95 million US, with a year end run rate of $109 million US. Doug's EBITDA estimate however is more in line with what I expect even with the higher revenues. Q1 EBITDA percentage of Revenue was lower and I expect it will be in Q2 as well due to the compensation based on the stock price and built of resources to support rapid expansion. I'm estimating a 25% number (as compared to 26.5% earlier) which puts the 2019 EBITDA at $23.75 million US or $31.8 million Canadian (84 cents per share x 15 = $12.56). With the US listing, I expect the multiple to be in the 15x range and possibly 20x given the rapid growth the company is embarking on. Management mentioned this "rapid growth" a number of times in the conference call and I sense there is more to what is clearly visible currently. Casey mentioned the hiring of registered nurses now which allows for expanded services, also mentioned the VA opportunity and the network of home care workers across the nation (within 18 months). The latter builds the underlying infrastructure to becoming the national home care provider which Casey has envisioned for VMD (take us to that Billion dollar revenue number in 10 years or less).
Bullboard Posts